Background/Aims: The ‘surprise question' (SQ) may aid timely identification of patients with end-of-life care needs. We assessed its prognostic value and variability among clinicians caring for a cohort of haemodialysis (HD) patients. Methods: Clinicians (29 nurses and 6 nephrologists) in each of our 3 HD units were asked to pose the SQ concerning all patients dialysing in their unit. There were 344 patients, 116 in Unit 1, 132 in Unit 2 and 96 in Unit 3. Results: An adverse SQ response: ‘I would not be surprised if this patient were to die in the next 12 months' was reported by individual clinicians for between 6 and 43% of patients (mean 24 ± 9%). Nephrologists responded adversely for more patients than nurses did. Fifty-two patients died during the 12 months of follow-up. There were wide variations between clinicians in the predictive power of SQ responses. Mean odds ratios were significantly higher for nephrologists than for nurses. SQ responses of 49% of clinicians improved baseline models of 12-month mortality, more so for nephrologists (67%) than for senior nurses (50%) and nurses of lesser seniority (36%). Unit performance differed significantly. Agreements between clinicians on SQ responses improved the positive predictive value, i.e. the more clinicians agreed on an adverse response, the greater its predictive power. Conclusion: SQ provides a unique contribution to the prediction of short-term prognosis in HD patients, though predictive power varies with clinical discipline, seniority and clinical setting. Agreements between clinicians on adverse responses may have clinical utility.

Keywords:
Haemodialysis, End-stage kidney disease, The ‘surprise question’
1.
Chandna SM, Schulz J, Lawrence C, Greenwood RN, Farrington K: Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity. BMJ 1999;318:217-223.
2.
Castledine C, Casula A, Fogarty D: Chapter 2 UK RRT prevalence in 2010: national and centre-specific analyses. Nephron Clin Pract 2012;120(suppl 1):c29-c54.
3.
Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002;347:2010-2019.
4.
Department of Health (2008): End-of-Life Care Strategy - promoting high quality care for all adults at the end of life. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_086345.pdf
5.
Moss AH: New guideline describes Nephrology Community Consensus on withholding and withdrawing dialysis. Recommendations regarding withdrawing dialysis. 2. Nephrol News Issues 2001;15:58-61.
6.
NHS Kidney Care: End-of-life care in advanced kidney disease: a framework for implementation. Department of Health, 2009. http://www.endoflifecareforadults.nhs.uk/publications/eolcadvancedkidneydisease
7.
Gold Standards Framework: Prognostic Indicator Guidance, ed 4. The Gold Standards Framework Centre CIC, October 2011. http://www.goldstandardsframework.org.uk/Resources/Gold%20Standards%20Framework/General/Prognostic%20Indicator%20Guidance%20October%202011.pdf
8.
Moss AH, Lunney JR, Culp S, Auber M, Kurian S, Rogers J, Dower J, Abraham J: Prognostic significance of the ‘surprise' question in cancer patients. J Palliat Med 2010;13:837-840.
9.
Murray S, Boyd K: Using the ‘surprise question' can identify people with advanced heart failure and COPD who would benefit from a palliative care approach. Palliat Med 2011;25:382.
10.
Moss AH, Ganjoo J, Sharma S, Gansor J, Senft S, Weaner B, Dalton C, MacKay K, Pellegrino B, Anantharaman P, Schmidt R: Utility of the ‘surprise' question to identify dialysis patients with high mortality. Clin J Am Soc Nephrol 2008;3:1379-1384.
11.
Cohen LM, Ruthazer R, Moss AH, Germain MJ: Predicting six-month mortality for patients who are on maintenance hemodialysis. Clin J Am Soc Nephrol 2010;5:72-79.
12.
Tattersall JE, DeTakats D, Chamney P, Greenwood RN, Farrington K: The post-hemodialysis rebound: predicting and quantifying its effect on Kt/V. Kidney Int 1996;50:2094-2102.
13.
Charlson ME, Pompei P, Ales KL, Mackenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
14.
Davison SN: End-of-life care preferences and needs: perceptions of patients with chronic kidney disease. Clin J Am Soc Nephrol 2010;5:195-204.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.